Ibrutinib in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Subjects With New Onset Chronic Graft Versus Host Disease (cGVHD) (INTEGRATE)
Phase of Trial: Phase III
Latest Information Update: 22 Nov 2017
At a glance
- Drugs Ibrutinib (Primary) ; Prednisone
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Acronyms iNTEGRATE
- Sponsors Pharmacyclics
- 06 Jun 2017 Trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 08 Dec 2016 Status changed from not yet recruiting to recruiting.
- 14 Nov 2016 New trial record